SEC Form 4 · accession 0001543209-16-000004
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles A. Nicolette
Officer — Chief Scientific Officer
Period of report
Jun 10, 2016
Accepted (ET)
Jun 14, 2016 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 13, 2016 | A | 10,924 | $0.00 | A | 76,043 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $6.09 | Jun 10, 2016 | A | 3,375 | A | Jun 10, 2016 | Jul 27, 2024 | Common Stock | 3,375 | 3,375 | D |
| Stock Option (right to buy)F4 | $7.41 | Jun 13, 2016 | A | 175,000 | A | — | Jun 12, 2026 | Common Stock | 175,000 | 175,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units vest in twelve equal monthly installments beginning June 30, 2016. Vested shares will be delivered to the reporting person on each vesting date.
- F2Includes 2,002 shares of common stock acquired pursuant to the 2014 Employee Stock Purchase Plan on March 10, 2016.
- F3On July 28, 2014, the reporting person was granted an option to purchase 27,000 shares of common stock. This option vests in installments based on the achievement of certain performance criteria considered to be under the control or supervision of the reporting person. A performance milestone related to the non-clinical development of AGS-003 was deemed achieved by the Compensation Committee of the Company, resulting in vesting of the option with respect to 3,375 shares.
- F4This option was granted on June 13, 2016 and vests as to 25% of the shares underlying this option on June 13, 2017, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning June 13, 2017.